← Back to context

Comment by idontwantthis

10 hours ago

As long as government regulation prevents them from forming a cartel.

It shouldnt be limited to companies within the country. Any foreign company can be a market disruptor here. Assuming the drug approval admin isnt working alongside the 'cartel'.

  • And only in the very particular scenario of a national-only cartel which has not successfully roped in other international pharma companies.

  • And then there's medical tourism, for the people who prefer to shop at one of the other 'cartels'